IndraLab

Statements


OTUD7B inhibits pathway. 5 / 5
| 5

sparser
"A previous study showed that OTUD7B can inhibit the NF-κB pathway in liver cancer [ xref ]."

sparser
"To examine the potential mechanism by which OTUD7B inhibits the LCL161-induced NF-κB pathway, we transfected Flag-TRAF3 and HA-OTUD7B, Myc-NIK and HA-OTUD7B into H1299 cells for 48 h."

sparser
"Previous studies have shown that OTUD7B inhibited NF-κB pathway by deconjugating K63-polyubiquitin chains from RIP-1 and TRAF6, suggesting that it may have roles in inhibition of cancer progression xref , xref ."

sparser
"The non-canonical pathway can be inhibited by OTUD7B or down-regulated by degradation of NIK."

sparser
"TI 8 , TI 11 , and TI 13 reflect the pathway from receptor stimulation to nuclear translocation, the regulative feedback loop of NIK degradation, and the regulative inhibition by OTUD7B, respectively,[MISSING/INVALID CREDENTIALS: limited to 200 char for Elsevier]"